MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC
NCT04633564
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
671
Enrollment
INDUSTRY
Sponsor class
Conditions
NSCLC Stage IV
Interventions
BIOLOGICAL:
Bevacizumab as MYL-1402O
BIOLOGICAL:
Bevacizumab as Avastin
Sponsor
Mylan Pharmaceuticals Inc